China Pharma Holdings, Inc. / Fundamentals
Income statement
- Net revenue
€969.20B - Cost of goods sold
€1.09T - Gross profit
-€116.05B - SG&A expenses
€506.90B - R&D expenses
€25.24B - EBITDA
-€647.07B - D&A
€1.25M - EBIT
-€647.07B - Interest expenses
-€23.91B - EBT
-€670.06B - Tax expenses
€625.89K - Net income
-€670.06B
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€357.00K - Changes in working capital
€1.25M - Operating cash flow
-€49.32B - Capex
€49.75B - Other investing cash flow
-€19.31B - Net investing cash flow
-€69.06B - Total cash dividends paid
€0.00 - Issuance of common stock
€1.16T - Debt repayment
-€13.31K - Other financing cash flow
-€59.73B - Net financing cash flow
-€59.73B - Foreign exchange effects
-€4.58B - Net change in cash
-€182.69B - Cash at end of period
€533.12K - Free cash flow
€428.83M
Balance sheet
- Cash and cash equivalents
€533.12K - Cash and short-term investments
€533.12K - Total receivables
€270.52K - Inventory
€1.43M - Other current assets
€68.10K - Total current assets
€2.30M - Property, plant & equipment
€3.61M - Goodwill
€0.00 - Intangible assets
€5.83M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€9.44M - Total assets
€11.74M - Accounts payable
€452.69K - Short-term debt
€1.80M - Other current liabilities
€1.53M - Total current liabilities
€4.48M - Long-term debt
€1.13M - Deferred tax liabilities
€626.28K - Other non-current liabilities
€0.00 - Total non-current liabilities
€1.75M - Total liabilities
€6.23M - Common stock
€2.78K - Retained earnings
-€38.67M - Other equity
€9.68M - Total equity
€5.51M - Total liabilities and shareholders' equity
€11.74M
Company information
- Market capitalization
€5.08M - Employees
224 - Enterprise Value
€1.00T
Company ratios
- Gross margin
-
-12.0% - EBITDA margin
-
-66.8% - EBIT margin
-
-66.8% - EBT margin
-
-69.1% - Net margin
-
-69.1% - ROE
-
-12,157,319.6% - ROA
-
-5,706,399.2% - Asset turnover
-
8,253,988.4% - FCF margin
-
-10.2% - FCF yield
-1,949,928.8% - Efficiency ratio
166.8% - Net sales per employee
-
€4.33B - Net income per employee
-
-€2.99B